Related Experiment Video

Updated: Jan 27, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

10.6K

[Invasive pulmonary aspergillosis in a patient with human immunodeficiency virus (HIV)]

Awatif El Hakkouni1, Nabil Mansouri2

  • 1Hôpital Ibn Zohr, Marrakech, Maroc.

The Pan African Medical Journal
|March 29, 2019
PubMed

Insights

Invasive pulmonary aspergillosis is a rare but serious infection in HIV patients, primarily caused by Aspergillus fumigatus. Early diagnosis via imaging, fluid analysis, and biopsy is crucial for effective treatment with voriconazole.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Invasive pulmonary aspergillosis (IPA) is a rare opportunistic infection in individuals with HIV/AIDS.
  • Prognosis for IPA in HIV-infected patients is generally poor.
  • Aspergillus fumigatus is the predominant fungal pathogen responsible for IPA.

Observation:

  • Early diagnosis of IPA is critical and relies on integrating clinical presentation, chest CT scans, and mycological data.
  • Direct examination and culture of bronchoalveolar lavage fluid (BALF) aid in identifying Aspergillus species.
  • Anatomopathological examination of CT-guided biopsies is essential for diagnosis in cases with negative BALF results.

Findings:

  • The Aspergillus galactomannan antigen test is a valuable diagnostic tool for IPA.
  • Voriconazole is recommended as the first-line treatment for IPA.
  • Careful consideration of potential drug interactions between voriconazole and highly active antiretroviral therapy (HAART) is mandatory.

Implications:

  • Timely and accurate diagnosis of IPA in HIV patients can significantly improve patient outcomes.
  • Integrated diagnostic approaches combining imaging, fluid analysis, and serology are vital.
  • Management requires a multidisciplinary approach, including infectious disease specialists and careful drug interaction monitoring.
Keywords:
HIVInvasive pulmonary aspergillosisculture

More Related Videos

Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR08:01

Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR

Published on: November 27, 2019

7.9K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.6K

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.1K
What are Viruses?00:50

What are Viruses?

Overview
127.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
885
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
565